Pancreatic Cancer Research

ResearcherDalhousie UniversityActive in the last 2 years

Sharon E. Clarke

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-5759-5808; OpenAlex author ID A5054145176. Sources: OpenAlex.

Their work

Papers
4 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2020: 1 paper · 2021: 2 papers · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 4

  1. Preoperative Soluble AXL in Plasma Predicts Futility of Resecting Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/curroncol33020088↗
  2. The implications of missed or misinterpreted cases of pancreatic ductal adenocarcinoma on imaging: a multi-centered population-based study. First author DOI 10.1007/s00330-020-07120-0↗
  3. Factors associated with missed and misinterpreted cases of pancreatic ductal adenocarcinoma. First author DOI 10.1007/s00330-020-07307-5↗
  4. Editorial for "Development of a Novel Multiparametric MRI Radiomic Nomogram for Preoperative Evaluation of Early Recurrence in Resectable Pancreatic Cancer". Co-author DOI 10.1002/jmri.27125↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ravi Ramjeesingh · 2 shared papers, 2021–2026 · strength 0.42
  2. Jessie Kang · 2 shared papers, 2021 · strength 0.38
  3. Andreu F. Costa · 2 shared papers, 2021 · strength 0.38
  4. Thomas Arnason · 1 shared paper, 2026 · strength 0.26
  5. Jeanette E. Boudreau · 1 shared paper, 2026 · strength 0.26
  6. Boris Gala-López · 1 shared paper, 2026 · strength 0.26
  7. Thomas Samson · 1 shared paper, 2026 · strength 0.26

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.